Keros Therapeutics's market cap is currently $427.76M. The company's EPS TTM is $-5.206; its P/E ratio is ―; Keros Therapeutics is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is $-1.36. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 151.00K	$ 0.00	$ 20.10M	$ 0.00	$ 10.00M
Gross Profit	$ -664.00K	$ -1.61M	$ 19.20M	$ -605.00K	$ -7.35M
Operating Income	$ -169.94M	$ -114.79M	$ -56.37M	$ -46.66M	$ -10.56M
EBITDA	$ -152.18M	$ -103.06M	$ -56.37M	$ -44.92M	$ -11.89M
Net Income	$ -152.99M	$ -104.68M	$ -58.74M	$ -45.36M	$ -12.34M
Balance Sheet
Cash & Short-Term Investments	$ 331.15M	$ 279.05M	$ 230.04M	$ 265.88M	$ 7.02M
Total Assets	$ 370.02M	$ 306.78M	$ 255.25M	$ 269.44M	$ 10.96M
Total Debt	$ 14.44M	$ 13.27M	$ 1.09M	$ 899.00K	$ 1.27M
Net Debt	$ -316.70M	$ -265.78M	$ -228.95M	$ -264.98M	$ -5.75M
Total Liabilities	$ 37.81M	$ 29.36M	$ 12.08M	$ 7.72M	$ 5.50M
Stockholders' Equity	$ 332.21M	$ 277.42M	$ 243.17M	$ 261.72M	$ 5.45M
Cash Flow
Free Cash Flow	$ -126.97M	$ -71.30M	$ -63.17M	$ -37.19M	$ -16.27M
Operating Cash Flow	$ -124.51M	$ -70.06M	$ -62.15M	$ -36.89M	$ -16.00M
Investing Cash Flow	$ -2.46M	$ -1.24M	$ -1.02M	$ -294.00K	$ -271.00K
Financing Cash Flow	$ 178.96M	$ 120.31M	$ 28.55M	$ 296.04M	$ 14.00K

Currency in USD

Keros Therapeutics Earnings and Revenue History

Income Statement >

Keros Therapeutics Debt to Assets

Balance Sheet >

Keros Therapeutics Cash Flow

Cash Flow >

Keros Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing